Flag of the European Union EU Clinical Trials Register Help

Clinical trials

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44380   clinical trials with a EudraCT protocol, of which   7392   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    44,380 result(s) found. Displaying page 33 of 2,219.
    EudraCT Number: 2007-004980-23 Sponsor Protocol Number: P05134 Start Date*: 2008-05-05
    Sponsor Name:Schering-Plough Farma, Lda.
    Full Title: Double-Blind evaluation of the safety and efficacy of Quadriderme cream (betamethasone dipropionate, clotrimazole and gentamicin sulphate ) compare with betamethasone dipropionate combined with gen...
    Medical condition: Impetiginous Eczema
    Disease: Version SOC Term Classification Code Term Level
    9.1 10051890 Eczema impetiginous LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: PT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-004985-41 Sponsor Protocol Number: DYSK-PD-2007 Start Date*: 2007-11-29
    Sponsor Name:Department of Neuroscience, neurology
    Full Title: Different dyskinesias in Parkinson's disease and their relation to levodopa pharmacokinetics
    Medical condition: Parkinson's disease, G20.9. Different dyskinesias related to advanced Parkinson's disease will be investigated.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004994-25 Sponsor Protocol Number: CSMS995A2101 Start Date*: 2008-02-04
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A multi-center, randomized, double-blind, placebo-controlled, crossover study in women with irritable bowel syndrome to evaluate feasibility and reproducibility of barostat assessments of colorecta...
    Medical condition: Irritable Bowel Syndrom
    Disease: Version SOC Term Classification Code Term Level
    9.1 10023003 Irritable bowel syndrome PT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2008-002335-32 Sponsor Protocol Number: AN08/8505 Start Date*: 2008-11-28
    Sponsor Name:The University of Leeds
    Full Title: Does concentration affect the ED50 of bupivacaine for supraclavicular brachial plxus block?
    Medical condition: Not applicable
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-002343-16 Sponsor Protocol Number: 1014/05 Start Date*: 2006-01-05
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: Postoperative nausea and vomiting: acupuncture effect on postoperative prevention
    Medical condition: Postoperative nausea and vomiting laparoscopic cholecistectomy
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008629 Cholelithiasis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-000526-48 Sponsor Protocol Number: A.S.T.R.A. Start Date*: 2007-03-06
    Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA
    Full Title: Randomized, monocentric trial on sintoms, adherence,toxicity of alternate antiretrovirale regimen
    Medical condition: PT HIV-1 positive and naive to antiretroviral drug
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020161 HIV infection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-001465-14 Sponsor Protocol Number: CSLCT-NHF-06-30 Start Date*: 2007-05-17
    Sponsor Name:CSL Limited
    Full Title: A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira Vaccine in Healthy Adults aged ≥ 18 to < 60 years and in Healthy Older Adults aged ≥ 60 years for the 2007/2008...
    Medical condition: Prophylaxis of Influenza
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-001187-78 Sponsor Protocol Number: 112897 Start Date*: 2008-01-02
    Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust
    Full Title: The 3Mg Trial: A randomised controlled trial of intravenous or nebulised magnesium sulphate versus standard therapy for acute severe asthma
    Medical condition: Acute severe asthma
    Disease: Version SOC Term Classification Code Term Level
    13.1 10038738 - Respiratory, thoracic and mediastinal disorders 10003566 Asthmatic attack LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-001206-24 Sponsor Protocol Number: 16901 Start Date*: 2007-07-31
    Sponsor Name:UMCG
    Full Title: Effect of selective COX-2 inhibition on neuroinflammation in Parkinson's disease
    Medical condition: Parkinson's disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-002109-32 Sponsor Protocol Number: CORL2007 Start Date*: 2007-05-10
    Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
    Full Title: USE OF FENOLDOPAM TO IMPROVE GLOMERULAR FILTRATION RATE IN EARLY RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION
    Medical condition: Adult liver transplanted patients age > 18 years , with pre-transplantation normal renal function creatinine clearance 1ml/kg/min
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038436 Renal failure acute LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-002120-14 Sponsor Protocol Number: 3074K4-2207-WW Start Date*: 2008-10-29
    Sponsor Name:Wyeth Research Division of Wyeth Pharmaceutical Inc.
    Full Title: A Multicenter, Open-Label, Ascending Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age With Selected Serious Infections
    Medical condition: Complicated intra-abdominal infections (cIAI), complicated skin and skin structure infections (cSSSI), community-acquired pneumonia (CAP).
    Disease: Version SOC Term Classification Code Term Level
    9.1 10056570 Intra-abdominal infection LLT
    9.1 10040872 Skin infection LLT
    9.1 10010120 Community acquired pneumonia LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed) GB (Completed) Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2008-001160-36 Sponsor Protocol Number: 2008-1 Start Date*: 2009-06-04
    Sponsor Name:Imperial College London
    Full Title: A trial of Guanfacine, an alpha 2 adrenergic agonist, for Spatial Neglect and Impaired Vigilance following Stroke and Focal Brain Damage
    Medical condition: Spatial Neglect following Hemispheric stroke and focal brain injury
    Disease: Version SOC Term Classification Code Term Level
    14.0 10029205 - Nervous system disorders 10050400 Vigilance decreased LLT
    14.0 10029205 - Nervous system disorders 10029289 Neurologic neglect syndrome PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-006405-17 Sponsor Protocol Number: FDM-study Start Date*: 2009-02-25
    Sponsor Name:Kuopio University Hospital
    Full Title: Finnish Dyspepsia Management -study
    Medical condition: Tutkimukseen rekrytoidaan n. 400 dyspepsiaoireiden vuoksi erikoissairaanhoitoon lähetettyä alle 60-vuotiasta potilasta, joiden vaiva tutkimusten jälkeen todetaan toiminnalliseksi.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013946 Dyspepsia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-004526-90 Sponsor Protocol Number: TaxErb-1 Start Date*: 2007-01-30
    Sponsor Name:Klinik Löwenstein gGmbH
    Full Title: TaxErb-Protokoll; Docetaxel-Carboplatin Chemotherapie in Kombination mit Cetuximab bei Patienten mit local fortgeschrittenem oder metastasiertem, nicht-kleinzelligem Bronchial-Karzinom (NSCLC)-ein ...
    Medical condition: Patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10066490 Progression of non small cell lung cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-000569-13 Sponsor Protocol Number: EMR 64300-608 Start Date*: 2006-04-21
    Sponsor Name:Cardioangiologisches Centrum Bethanien
    Full Title: Influence on the coronary Microcirculation and on myocArdial perfusion Reserve of Niaspan given IN addition to simvastatin in diabEtic patients
    Medical condition: Diabetic patients at high risk for CVD
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-000571-15 Sponsor Protocol Number: 101-PG-COM-143 Start Date*: 2007-07-13
    Sponsor Name:Laboratorios LETI S.L.
    Full Title: Extracto alergénico despigmentado polimerizado de Dermatophagoides pteronyssinus como tratamiento antiasmático en niños con asma leve alérgicos a ácaros.
    Medical condition: Asma leve por alergia a ácaros
    Disease: Version SOC Term Classification Code Term Level
    8.1 10003553 Asthma LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-001984-53 Sponsor Protocol Number: ETHIG II Start Date*: 2006-10-11
    Sponsor Name:Friedrich-Schiller-Universität Jena
    Full Title: Effectiveness of Dalteparin Therapy as Intervention in recurrent pregnancy loss
    Medical condition: Pregnant women with a history of recurrent pregnancy loss, defined as: - 2 or more early (< 12 weeks of gestation) pregnancy losses or - 1 or more late (> 12 weeks of gestation) pregnancy loss
    Disease: Version SOC Term Classification Code Term Level
    8.1 10036562 Pregnancy in habitual aborter LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2007-001816-22 Sponsor Protocol Number: V150960 Start Date*: 2007-10-19
    Sponsor Name:Anne Ristikankare
    Full Title: Vasopressiinin vaikutus munuaisten toimintaan sydänleikkauksen jälkeisessä vasodilatoivassa shokissa
    Medical condition: sydänleikkauspotilaita, joilla on perfuusion jälkeinen vasodilatoiva shokki
    Disease: Version SOC Term Classification Code Term Level
    9.1 10048348 Hypotension aggravated LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-002791-18 Sponsor Protocol Number: 0476-302 Start Date*: 2006-09-28
    Sponsor Name:Suomen MSD Oy
    Full Title: A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study Evaluating the Effects of 2 Different Regimens of Montelukast (Daily Dosing and Intermittent, Episode-Driven Dosing) Comp...
    Medical condition: episodic or intermittent asthma
    Disease: Version SOC Term Classification Code Term Level
    8.1 10003553 Asthma LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: FI (Completed) DK (Completed) DE (Completed) IT (Completed) LT (Completed) FR (Completed) Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2006-002793-21 Sponsor Protocol Number: Lactest2-06 Start Date*: 2006-11-14
    Sponsor Name:Lactest S.L.
    Full Title: “ Ensayo Clinico para la evaluación no invasiva de la actividad lactasa intesttinal in vivo, mediante la administracción oral de 4-Galactosil-xilosa en sujetos con clinica sugerente de intolerancia...
    Medical condition: Diagnostico no invasivo de la deficiencia de lactasa intestinal
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue Feb 10 04:46:05 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA